Pro Share Advisors LLC Homology Medicines, Inc. Transaction History

Pro Share Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.39 - $3.12 $19,148 - $42,981	-13,776 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$2.6 - $4.17 $8,938 - $14,336	-3,438 Reduced 19.97%	13,776 $42,000
Q4 2021 Feb 08, 2022	SELL	$3.64 - $7.78 $1,288 - $2,754	-354 Reduced 2.02%	17,214 $62,000
Q3 2021 Nov 12, 2021	SELL	$6.01 - $8.71 $21,461 - $31,103	-3,571 Reduced 16.89%	17,568 $138,000
Q2 2021 Aug 13, 2021	BUY	$6.02 - $9.64 $34,813 - $55,748	5,783 Added 37.66%	21,139 $154,000
Q1 2021 May 14, 2021	BUY	$9.17 - $14.8 $7,711 - $12,446	841 Added 5.79%	15,356 $144,000
Q4 2020 Feb 09, 2021	BUY	$8.92 - $13.29 $27,420 - $40,853	3,074 Added 26.87%	14,515 $164,000
Q3 2020 Nov 13, 2020	SELL	$9.94 - $16.59 $4,015 - $6,702	-404 Reduced 3.41%	11,441 $122,000
Q2 2020 Aug 03, 2020	BUY	$12.07 - $19.34 $142,969 - $229,082	11,845 New	11,845 $180,000
Q1 2020 May 15, 2020	SELL	$12.5 - $22.04 $161,037 - $283,941	-12,883 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$11.42 - $22.19 $21,024 - $40,851	-1,841 Reduced 12.5%	12,883 $267,000
Q3 2019 Nov 12, 2019	BUY	$14.74 - $22.28 $2,564 - $3,876	174 Added 1.2%	14,724 $267,000
Q2 2019 Aug 13, 2019	SELL	$18.35 - $30.34 $1,027 - $1,699	-56 Reduced 0.38%	14,550 $285,000
Q1 2019 May 15, 2019	BUY	$19.76 - $29.57 $1,719 - $2,572	87 Added 0.6%	14,606 $405,000
Q4 2018 Feb 14, 2019	BUY	$18.39 - $26.3 $267,004 - $381,849	14,519 New	14,519 $325,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.